| Authors: |
Bajbouj K; Department of Biomedical Sciences, University of Pennsylvania, Philadelphia, Pennsylvania., Xiao Z; Department of Biomedical Sciences, University of Pennsylvania, Philadelphia, Pennsylvania., Todd L; Department of Biomedical Sciences, University of Pennsylvania, Philadelphia, Pennsylvania., Huang L; Department of Biomedical Sciences, University of Pennsylvania, Philadelphia, Pennsylvania., Papp TE; Division of Infectious Diseases, Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania., Halilovic F; Division of Infectious Diseases, Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania., Ramani J; Division of Infectious Diseases, Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania., Bao Y; Capstan Therapeutics, San Diego, California., Butcher M; Capstan Therapeutics, San Diego, California., Bot A; Capstan Therapeutics, San Diego, California., Aghajanian H; Capstan Therapeutics, San Diego, California., June CH; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania., Weissman D; Penn Institute for RNA Innovation, University of Pennsylvania, Philadelphia, Pennsylvania., Parhiz H; Division of Infectious Diseases, Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania.; Penn Institute for RNA Innovation, University of Pennsylvania, Philadelphia, Pennsylvania., Albelda SM; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Puré E; Department of Biomedical Sciences, University of Pennsylvania, Philadelphia, Pennsylvania.; Division of Infectious Diseases, Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania. |
